Business Description
Kissei Pharmaceutical Co Ltd
NAICS : 325412
ISIN : JP3240600001
Share Class Description:
KSPHF: Ordinary SharesDescription
Kissei Pharmaceutical Co Ltd is a specialty and generic drug manufacturing company. Pharmaceuticals is the company's reportable segment. The company's operations span across the globe, while the vast majority of revenue is generated in Japan, followed by Europe. Kissei operates a variety of subsidiaries. The company considers merger and acquisition investment as a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 34.28 | |||||
| Equity-to-Asset | 0.84 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | 0.09 | |||||
| Interest Coverage | 252.28 | |||||
| Piotroski F-Score | 6/9 | |||||
| Altman Z-Score | 4.06 | |||||
| Beneish M-Score | -1.98 | |||||
| WACC vs ROIC | ||||||
Growth Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 4.1 | |||||
| 3-Year EBITDA Growth Rate | 21.9 | |||||
| 3-Year EPS without NRI Growth Rate | 29.3 | |||||
| 3-Year FCF Growth Rate | 3.5 | |||||
| 3-Year Book Growth Rate | 1.5 | |||||
| Future 3-5Y Total Revenue Growth Rate | 5.33 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 100 | |||||
| 9-Day RSI | 99.99 | |||||
| 14-Day RSI | 99.7 | |||||
| 6-1 Month Momentum % | -6.12 | |||||
| 12-1 Month Momentum % | 14.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 5.92 | |||||
| Quick Ratio | 4.43 | |||||
| Cash Ratio | 2.6 | |||||
| Days Inventory | 229.97 | |||||
| Days Sales Outstanding | 123.59 | |||||
| Days Payable | 45.4 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 2.29 | |||||
| Dividend Payout Ratio | 0.87 | |||||
| 3-Year Dividend Growth Rate | 14.9 | |||||
| Forward Dividend Yield % | 2.34 | |||||
| 5-Year Yield-on-Cost % | 3.95 | |||||
| 3-Year Average Share Buyback Ratio | 1.4 | |||||
| Shareholder Yield % | 2.4 |
Profitability Rank
6/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 49.9 | |||||
| Operating Margin % | 5.87 | |||||
| Net Margin % | 15.5 | |||||
| FCF Margin % | -4.53 | |||||
| ROE % | 5.96 | |||||
| ROA % | 5.14 | |||||
| ROIC % | 1.94 | |||||
| ROC (Joel Greenblatt) % | 23.86 | |||||
| ROCE % | 7.21 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 14 | |||||
| Forward PE Ratio | 14.13 | |||||
| PE Ratio without NRI | 39.43 | |||||
| Shiller PE Ratio | 20.79 | |||||
| PEG Ratio | 1.83 | |||||
| PS Ratio | 2.17 | |||||
| PB Ratio | 0.76 | |||||
| Price-to-Tangible-Book | 0.76 | |||||
| EV-to-EBIT | 7.78 | |||||
| EV-to-EBITDA | 7.78 | |||||
| EV-to-Revenue | 1.57 | |||||
| EV-to-FCF | -34.65 | |||||
| Price-to-Projected-FCF | 0.91 | |||||
| Price-to-Median-PS-Value | 1.2 | |||||
| Price-to-Peter-Lynch-Fair-Value | 1.78 | |||||
| Price-to-Graham-Number | 1.23 | |||||
| Price-to-Net-Current-Asset-Value | 2.61 | |||||
| Price-to-Net-Cash | 32.89 | |||||
| Earnings Yield (Greenblatt) % | 12.85 | |||||
| FCF Yield % | -2.11 | |||||
| Forward Rate of Return (Yacktman) % | 20.02 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with OTCPK:KSPHF
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Kissei Pharmaceutical Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 516.853 | ||
| EPS (TTM) ($) | 1.78 | ||
| Beta | 0.46 | ||
| Volatility % | 29.46 | ||
| 14-Day RSI | 99.7 | ||
| 14-Day ATR ($) | 0.106708 | ||
| 20-Day SMA ($) | 23.76765 | ||
| 12-1 Month Momentum % | 14.19 | ||
| 52-Week Range ($) | 18.81 - 25 | ||
| Shares Outstanding (Mil) | 44.21 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Kissei Pharmaceutical Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Kissei Pharmaceutical Co Ltd Stock Events
| Event | Date | Price($) | ||
|---|---|---|---|---|
| No Event Data | ||||
Kissei Pharmaceutical Co Ltd Frequently Asked Questions
What is Kissei Pharmaceutical Co Ltd(KSPHF)'s stock price today?
The current price of KSPHF is $25.00. The 52 week high of KSPHF is $25.00 and 52 week low is $18.81.
When is next earnings date of Kissei Pharmaceutical Co Ltd(KSPHF)?
The next earnings date of Kissei Pharmaceutical Co Ltd(KSPHF) is .
Does Kissei Pharmaceutical Co Ltd(KSPHF) pay dividends? If so, how much?
The Dividend Yield %  of Kissei Pharmaceutical Co Ltd(KSPHF) is 2.29% (As of Today), Highest Dividend Payout Ratio of Kissei Pharmaceutical Co Ltd(KSPHF) was 14.2. The lowest was 0.26. And the median was 0.67. The  Forward Dividend Yield % of Kissei Pharmaceutical Co Ltd(KSPHF) is 2.34%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers